Rochelle J. D'souza

300 Herston Road, Herston
Brisbane, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Journal: Oncogene

Published: March 03, 2025

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.

Journal: Acta neuropathologica communications

Published: September 17, 2024

EphA3 CAR T cells are effective against glioblastoma in preclinical models.

EphA3 CAR T cells are effective against glioblastoma in preclinical models.

Journal: Journal for immunotherapy of cancer

Published: July 18, 2024

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Journal: Oncogene

Published: February 14, 2024

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.

Journal: Research square

Published: June 19, 2023

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Journal: Nature communications

Published: May 17, 2023

Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

Journal: Scientific reports

Published: January 23, 2020

Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture.

Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture.

Journal: Cells

Published: December 30, 2019

Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore.

Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore.

Journal: Neuro-oncology

Published: September 11, 2019

The dystroglycan receptor maintains glioma stem cells in the vascular niche.

The dystroglycan receptor maintains glioma stem cells in the vascular niche.

Journal: Acta neuropathologica

Published: May 09, 2019

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.

Journal: Cancers

Published: December 24, 2018

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

Journal: Scientific reports

Published: August 02, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026